RSS
thrombosis
Verseon anti-coagulant drugs – new data highlights low bleed risk
Verseon presents further trial data on the low bleeding risk of its family of preclinical anti-coagulant drugs at BioEurope conference more
Drug-eluting stent demonstrates reduced thrombosis risk
Positive new data regarding BIOTRONIK's hybrid drug-eluting stent (DES) Orsiro was presented at EuroPCR 2015 in Paris, France. more
